Nyla A. Heerema

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Richard R. Furman, Steven Coutré et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

Kathryn G. Roberts, Yongjin Li, Debbie Payne-Turner et al. · New England Journal of Medicine · 2014 · 1.4K citations · Full text

Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice

Stefan Costinean, Nicola Zanesi, Yuri Pekarsky et al. · Proceedings of the National Academy of Sciences · 2006 · 938 citations · Full text

Hematological Malignancy, Tumor Biology, Lymphoid Neoplasia +15

Multiplex PCR: Critical Parameters and Step-by-Step Protocol

Octavian Henegariu, Nyla A. Heerema, S. R. Dlouhy et al. · BioTechniques · 1997 · 931 citations · Full text

Engineering, Dna Analysis, Molecular Biology +18

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema et al. · New England Journal of Medicine · 2018 · 927 citations · Full text